baber/WOPTO huggingface dataset:
Patent EP-0499069-A1 (EP)
Inventor: REISINGER GERHARD
IPC: B29B7/76
Filed: 1992-01-24
Abstract: Die Mischvorrichtung, die wie eine bekannte Mischvorrichtung mit Rücklaufnuten (18,19) im Steuerkolben (2) aufgebaut ist, ist dadurch gekennzeichnet, daß die Rücklaufnuten (18,19) eine Länge aufweisen, die gleich dem Absatnd der durch sie zu verbindenden Eintritts- und Rücklauföffnungen (4 bis 7) ist, wobei der Steuerkolben (2) in eine Zwischenstellung (B), in der die Rücklaufnuten (18,19) die Eintrittsöffnungen (4,5) mit den zugeordneten Rücklauföffnungen (6,7) verbinden, und in eine weiter vorgeschobene Räumstellung (c) bewegbar ist, in der die Rücklaufnuten nicht mehr mit den Rücklauföffnungen verbunden sind. Durch die kurzen Rücklaufnuten, deren Länge nicht mehr von der Länge der Mischkammer bzw. des Austrittsrohres der Mischkammer abhängig ist, wird die Gesamtbaulänge der Mischvorrichtung verkürzt. Sie beträgt nur noch das Zweifache des Hubes des Steuerkolbens. Der Halsbereich des Steuerkolbens wird verkürzt, wodurch die Klebefläche verkleinert wird. Bei langem Auslaufrohr ist die Mischvorrichtung dennoch kurz. <IMAGE>
Patent EP-0498460-A1 (EP)
Inventor: JAIN KRISHNA M
IPC: A61B19/02
Filed: 1992-02-07
Abstract: A surgical needle package counter (10,12) is particularly constructed for receiving and snugly retaining an opened surgical needle package (20) sequentially in a number of slots (18) particularly configured and sized to receive such opened surgical needle packages (20). Each slot (18) for receiving an opened surgical needle package (20) is identified by a number with the numbers (24) being in sequence so that an immediate total number of opened surgical needle packages (20) stored in the counter (12) may be observed. The surgical needle package counter (12) may have an integral extension (28) in which a foam filler (32) or slab may be seated. The foam filler (32) or slab is particularly formed to receive used surgical needles. Preferably, each used surgical needle will be received in a needle receiving zone which corresponds with the slot (18) of the surgical needle package counter (12) so that the number of used surgical needles can be automatically identified by the numerals (24) which identify the surgical package slots (18). A suitable cover (26) is provided for retaining the used surgical needles for disposal or possible future recount.
Patent EP-0508328-A1 (EP)
Inventor: NAGANO MASASHI
IPC: B62M3/00
Filed: 1992-04-03
Abstract: A gear crank (3) apparatus for a bicycle for supporting a plurality of chainwheels (G1,G2,G3). This apparatus includes a boss (5) secured to an end of a crank axle (7), a chainwheel supporting member (2) extending radially outwardly from the boss for supporting the chainwheels axially spaced apart from one another, and a crank. 
     The crank includes a first crank portion (3b) extending radially outwardly from the boss (5) and inclined axially outwardly away from a side face of an adjacent chainwheel supported by the chainwheel supporting member (2) to a position adjacent an outer periphery of the adjacent chainwheel, and a second crank portion (3a) extending from the first crank portion in a direction substantially perpendicular to the axis. 
     The chainwheel supporting member extends from the boss as inclined axially inwardly away from the crank means, and includes chainwheel mounting surfaces formed in peripheral regions thereof band extending perpendicular to the axis for attaching the chainwheels.
Patent EP-0513810-A1 (EP)
Inventor: GARLAND ROBERT BRUCE
IPC: C07C257/18
Filed: 1992-05-15
Abstract: The present invention relates to a class of compounds represented by the formula:
       
 or a pharmaceutically acceptable salt thereof, wherein W is the radical OR₁ wherein R₁ is hydrido, alkyl, phenyl, phenylalkyl which may be further substituted; or W is the amino radical of the formula NHOH; R₂ is hydrido, alkyl, alkenyl, cycloalkyl, cycloalkenyl which may be further substituted; or R₂ is phenyl, phenylalkyl, naphthyl, naphthylalkyl which may be further substituted; or R₂ is a heteromonocyclic ring structure having 5 or 6 ring carbon atoms wherein 1 or 2 of the ring carbon atoms are replaced by nitrogen, oxygen or sulfur and wherein the ring is selected from saturated, partially unsaturated, and fully unsaturated rings or a fused bicyclic ring structure having 10 to 12 ring carbon atoms wherein 1 to 3 of the ring carbon atoms may be replaced by nitrogen, oxygen or sulfur and each ring may independently be saturated, partially unsaturated or fully unsaturated which may be further stituted; R₃ and R₄ are each independently selected from hydrido, alkyl having 1 to 6 carbon atoms, hydroxy and halo; R₅ and R₆ are each independently selected from hydrido, alkyl having 1 to 6 carbon atoms, hydroxy, halo and alkoxy having 1 to 6 carbon atoms; and Y is alkyl having 1 to 6 carbon atoms, alkenyl having 2 to 6 carbon atoms, alkynyl having 2 to 6 carbon atoms or carbonylalkyl which may be further substituted. 
     Such compounds and compositions thereof have usefulness as inhibitors of platelet aggregation.
Patent EP-0532833-A1 (EP)
Inventor: MACEK JOSEPH
IPC: A61K39/27
Filed: 1992-05-15
Abstract: A combination vaccine which is effective against Equine rhinopneumonitis is made by combining an inactivated Equine herpesvirus type 1 with an inactivated Equine herpesvirus type 4 and an adjuvant. The herpesvirus type 1 and herpesvirus type 4 are combined in ratios of from about 4:1 to about 1:1. The adjuvant is preferably Havlogen, a Carbopol acrylic-based adjuvant.
Patent EP-0520510-A1 (EP)
Inventor: MITA RYUICHI
IPC: C07C17/42
Filed: 1992-06-26
Abstract: A triethylene glycol derivative is added to p-dichlorobenzene so as to prevent consolidation and improve flowability of p-dichlorobenzene.
Patent EP-0525519-A1 (EP)
Inventor: KUPCZYK ANDREAS
IPC: B32B7/028
Filed: 1992-07-15
Abstract: The invention relates to shrinkable composite sheets (V) or composite sheet sections (VA) which consist of shrinkable flat sheets (F1, F2) firmly bonding to one another. The directions (SRF1, SRF2) of shrinkage of the individual flat sheets (F1, F2) run at a suitable offset angle (A + B), so that overall resulting directions (SRV, SRVA) of shrinkage result for the composite sheet (V) or composite sheet sections (VA). The tendency of the shrinkable composite sheets (V) or composite sheet sections (VA) to tear or for tears to spread is thus reduced. <IMAGE>
Patent EP-0541928-A1 (EP)
Inventor: BOGGENSTALL LUDGER
IPC: B64D9/00
Filed: 1992-09-14
Abstract: The proposed device is used for locking a load (1) in the region of an aircraft cargo bay. For this purpose, the device is provided with at least one locking element (2) which can be positioned and is supported such that it can move relative to a frame (3). Arranged in the region of the frame is a sensor (4) which is connected to a monitoring unit (6) and detects at least one locking positioning and one unlocking positioning such that it is possible to differentiate between them. <IMAGE>
Patent EP-0541939-A1 (EP)
Inventor: BRECKWOLDT JOERN DR
IPC: C08B11/193
Filed: 1992-09-28
Abstract: Die Erfindung betrifft wasserlösliche polymerisierbare 3-Allyloxy-2-hydroxypropylether der Cellulose sowie ein Verfahren zu deren Herstellung.
Patent EP-0538848-A1 (EP)
Inventor: LAGANA VINCENZO
IPC: C07C237/04
Filed: 1992-10-22
Abstract: Process for the hydrolysis of urea contained in the process water from plants for the synthesis of urea consisting of the thermic treatment of the water containing urea and of the removal by stripping of the compounds from decomposition of the urea (CO2 and NH3) in a series of stages in series with superimposed flow. 
     The equipment is a vertical column with superimposed modules (S1,S2,S3...) with weirs (TP1,TP2,TP3...) which penetratein two successive modules and give the solution a rising movement.
Patent EP-0538862-A1 (EP)
Inventor: YONEYMA HIROYUKI
IPC: G03C7/392
Filed: 1992-10-22
Abstract: A silver halide color photographic material comprising a support having thereon a yellow color forming silver halide emulsion layer, a magenta color forming silver halide emulsion layer and a cyan color forming silver halide emulsion layer. The yellow color forming emulsion layer contains a silver halide emulsion having a silver chloride content of not less than 90 mol%, a yellow coupler and a bisphenol compound and optionally a difficultly water-soluble epoxy compound. One or more layers of the light-sensitive material may contain an ultraviolet light absorber.
Patent EP-0495639-A1 (EP)
Inventor: HSU DI-HWEI
IPC: C07K14/05
Filed: 1992-01-15
Abstract: A method is provided for using interleukin-10 in adoptive immunotherapy of cancer. A population of tumor-infiltrating lymphocytes (TILs) are expanded in culture in the presence of interleukin-2 (IL-2) and interleukin-10 (IL-10). After administration of the TILs to a patient, effective amounts of both IL-2 and IL-10 are administered to enhance the tumor-cell cytoxicity of the TILs and to reduce side-effects caused by IL-2-induced cytokine production in the TILs and other cells of the patient.
Patent EP-0544512-A1 (EP)
Inventor: WATANABO MASANORI
IPC: H01L33/38
Filed: 1992-11-25
Abstract: A surface electrode (316) on a surface (330) of a LED has a pad (318), and further, at least first-order branches (319a, ..., 319d) linearly extending from the pad (318), second-order branches (320a, 320b, and 320c) diverged and linearly extending from the first-order branches (319a, ..., 319d), and third-order branches (322a, 322b, and 322c) diverged and linearly extending from the second-order branches (320a, 320b, and 320c). The pad (318) out of the surface electrode (316) is not in electrical contact with a underlying semiconductor layer (331), whereas the surface electrode (316) and the semiconductor layer (331) are in electrical contact with each other at ends of the highest-order branches (322a, 322b, and 322c). Also, the semiconductor layer is provided along a pattern of the surface electrode in a mesa shape. Thus, ineffective light emission underneath the surface electrode (316) is relatively reduced so that external quantum efficiency can be improved, and moreover even shorter-wavelength light can be allowed to go out at high efficiency by omitting a current diffusion layer.
Patent EP-0547884-A1 (EP)
Inventor: IKEDA MITSUSHI
IPC: H01L21/311
Filed: 1992-12-16
Abstract: A method of manufacturing a semiconductor device, which comprises steps of providing a substrate (10), forming an oxide layer of a metal material, which includes tantalum, a tantalum compound or an alloy mainly containing tantalum on the substrate, placing the substrate into a first chamber (14), activating an etching gas which includes a fluorine containing gas and an oxygen containing gas, in a second chamber, introducing the activated etching gas into the first chamber (14), and etching the oxide layer by the introduced gas selectively against the substrate. A method of manufacturing a liquid crystal display device, comprises steps of providing a substrate (10), forming an anodic oxide layer of a tantalum containing material on the substrate, forming an etching mask on the anodic oxide layer, placing the substrate into a first region (14), activating a mixture of fluorine and oxygen containing gas in a second region, apart from the first region, introducing the activated etching gas into the first region (14) through a gas introducing portion (16), and etching the oxide layer on the substrate (10) selectively against the substrate, by using the etching mask.
Patent EP-0499518-A1 (EP)
Inventor: SNAITH RAYMOND E
IPC: E04H9/02
Filed: 1992-02-10
Abstract: An isolator (10) with improved uniform spring characteristic response resists transmission of shock and vibration forces between structures, and includes a plurality of arched, individual, flexural support elements (44) arranged circumferentially about an upright axis (B) and spanning the distance between a base (12,14) connectable to one of the structures, and an elevated support (32,34) connectable to another of the structures.
Patent EP-0530066-A1 (EP)
Inventor: ERRAMOUN DOMINIQUE
IPC: G06F13/24
Filed: 1992-07-27
Abstract: The interrupt controller according to the invention comprises means for memory storage (2) of the interrupt requests originating from the interrupt sources, an interrupt mask register (7) making it possible individually, by programming, to inhibit or enable each interrupt level, means for memory storage (8) of a plurality of vectors each corresponding to an interrupt source, means for memory storage (6) of the highest-priority vector, being serviced, comparison means (9) for systematically comparing each of the active and non-masked vectors with the vector stored in memory in the means (6) and for loading the said means (6) with the highest-priority vector, and means (5) for contention transmission, on a databus (D7-0) of the highest-priority vector. The invention applies to microprocessor interrupt systems, intended to receive interrupt requests from a plurality of interrupt sources. <IMAGE>
Patent EP-0539266-A1 (EP)
Inventor: BOUCARD JEAN THOMSON-CSF
IPC: H04B10/80
Filed: 1992-10-13
Abstract: The system according to the invention comprises at least one optical energy source (1), optical means (L1, 3, L2) of transmitting and collecting the optical power signals transmitted by the source, and a pyroelectric element (6) whose thermal cutoff frequency is greater than the frequency of modulation of the optical signals transmitted by the source (1). The pyroelectric element (6) converts the optical energy into electrical energy which is shaped by associated processing circuits (5). Application: remote optical supplies. <IMAGE>
Patent EP-0500500-A1 (EP)
Inventor: QUEZEL CASTRAZ MARC JOSEPH ANT
IPC: E06B9/323
Filed: 1992-02-19
Abstract: Actuation mechanism for venetian blind comprising a casing (1) in which pulleys (8, 9, 10) are installed, each one being installed rotationally in a cradle (11, 12, 13). The motor (5) is a tubular motor installed inside the actuation shaft (4). This shaft is supported at its ends and at least the intermediate cradle (11) is loosely installed in the casing. This installation makes it possible to align the axes of the pulleys with the axis of the actuation shaft. <IMAGE>
Patent EP-0511187-A1 (EP)
Inventor: VAN GYSEL AUGUST
IPC: C07D409/04
Filed: 1992-03-30
Abstract: Process for the preparation of 1H-benzimidazoles substituted in position 2, preferably those corresponding to the general formula <IMAGE>  in which   R1 represents a linear or branched alkyl containing 1 to 13 carbon atoms, a phenyl, halophenyl, 4-nitrophenyl, 4-methylphenyl, 4-cyanophenyl, 4-carboxyphenyl, benzyl, thienyl, furanyl, pyridyl, or 1,3- or 1,4-phenylene, R2 represents a hydrogen or chlorine atom, nitro or carboxyl, 2-(4-chlorophenyl)-1H-benzimidazol-5-yl, or 2-(4-carboxyphenyl)- 1H-benzimidazol-5-yl, and   n is equal to 1 or 2.   According to the invention, an aldehyde, a thionyl halide and a nitrogen-containing aromatic heterocyclic compound are reacted together, the product formed is then reacted with an optionally substituted 1,2-benzenediamine and the 1H-benzimidazole thus obtained is separated from the reaction mixture. Using this process, 1H-benzimidazoles are obtained in a single stage, under moderate conditions, with very high yields.
Patent EP-0516610-A1 (EP)
Inventor: LUEBBERS DIETRICH W PROF DR ME
IPC: C12Q1/54
Filed: 1992-04-27
Abstract: In an equipment for the determination of the flux of matter (substance flow) through an interface, it is arranged that there is at least one sensor layer (4; 9) which can be assigned to the interface (3) and which opposes the flux of matter with a known or predeterminable finite resistance, that an optical indicator (8; 8') for determining a first measured value of a variable which depends on the mean concentration of matter in the sensor layer (4) is provided in the sensor layer (4; 9), that a second measured value of said variable on one side of the sensor layer (4) is known or can be determined by a further optical indicator (8') present in the second sensor layer (9), and that an evaluation device (7) is provided for determining the flux of matter from the difference between the two measured values. <IMAGE>
Patent EP-0626806-A1 (EP)
Inventor: KATZ LEONARD
IPC: C12P19/62
Filed: 1992-01-17
Abstract: Procédé de production de nouvelles structures de polycétides dans lequel on détermine et on introduit des modifications prédéterminées dans l'ADN commandant la synthèse du polycétide. On effectue la biosynthèse d'analogues de polycétides spécifiques en modifiant un microorganisme producteur de polycétide par manipulation génétique en isolant une séquence d'ADN contenant un gène biosynthétique de polycétide, en identifiant les activités enzymatiques associées au sein de la séquence d'ADN, en introduisant une ou plusieurs modifications prédéterminées dans la séquence d'ADN qui code une des activités enzymatiques produisant une séquence d'ADN modifiée, en introduisant cette séquence d'ADN modifiée dans le microorganisme producteur de polycétide à la place de la séquence d'origine, en cultivant le microorganisme modifié dans des conditions adaptées à la formation de l'analogue du polycétide spécifique, puis en isolant l'analogue du polycétide spécifique de cette culture. Ce procédé est plus particulièrement utile lorsque le segment du chromosome modifié est impliqué dans une activité enzymatique associée à la biosynthèse du polycétide, plus spécifiquement pour manipuler des gènes de polycétide synthase provenant du genre Saccharapolyspora ou du genre Streptomyces.
Patent EP-0570507-A1 (EP)
Inventor: ALI FADIA EL-FEHAIL
IPC: C07D209/44
Filed: 1992-02-05
Abstract: L'invention se rapporte à des composés de la formule D-E-Asp-Q-Y où Q représente NH, NCH3 ou O; Y représente phényle, naphtyle, ou Het, non substitué ou substitué par un à trois alkyle C1-6, trifluorméthyle, halogène, OR', SR', (CH2)nAr, CONR1R2, CO2R2, CO2R2 or R4R4N; D représente (A) ou (B); W représente NHR', NR'C(=NH)NHR', NR'C(=NH)R' ou (C=NH)NHR'; U représente CO, SO2, NHCO, (CH2)n, SO2NH, NHSO2 or OC(=O); V représente H, R', R4R5N, R4R5NCO, R'O, Y-NR', X-A-B-NR' ou (C); A est absent ou représente Asn, Gln, Ala, Pro or Abu; B représente un acide aminé D- ou L- chosi à partir de Arg, HArg, NArg, (Me2)Arg, (Et2)Arg, Abu, Ala, Gly, His, Orn, Lys, Phg ou un dérivé substitué par alpha-R', Dtc, Tpr ou Pro; E représnte Gly, Sar, CH2CO ou NHCO; R' représente H, alkyle C1-6 ou Ar(CH2)p; X représente R4R4N, R4R5N-CO ou H; R1 et R2 représentent H, alkyle C1-6 ou(CH2)pAr; R4 représente H ou alkyle C1-6; R5 représente R6, R6CO, R6OCO, R6OCH(R6')CO, R6NHCH(R6')CO, R6SCH(R6')CO, R6SO2 ou R6SO; R6 et R6' représentent H, alkyle C1-6, cycloalkyle C3-7, Ar, Ar-alkyle C1-4, Het, Het-alkyle C1-4, Ar-(CH2)pCH(Ar)(CH2p ou Ar-cycloalkyle C3-7; Ar représente phényle ou phényle substitué par un à trois alkyle C1-6, trifluorométhyle, halogène, R'O ou R'S; et (C) représente un noyau mono ou bicyclique à cinq ou six éléments, contenant un ou deux atomes d'azote; m vaut (1) 0-4 lorsque W représente N'-(C=NH)NHR', (2) 0-5 lorsque W représente (C=NH)NHR' ou NR'(C=NH)R'; ou (3) 0-6 lorsque W représente NHR'; n vaut 0-2; p vaut 0-3; q vaut (1) 1-4 lorsque W représente NR'-(C=NH)NHR'; (2) 2-5 lorsque W représente (C=NH)NHR' ou NR'(C=NH)R'; ou (3) 3-6 lorsque W représente NHR'. L'invention se rapporte aussi à un sel pharmaceutiquement acceptable de ces composés, lesquels inhibent efficacement l'agrégation plaquettaire, ainsi qu'à des compositions pharmaceutiques favorisant une telle activité et à un procédé servant à inhiber l'agrégation plaquettaire.
Patent EP-0577657-A1 (EP)
Title: Layered mixed metal hydroxides for the stabilization of radioactive colloids
Inventor: SIMON JAIME
IPC: A61K51/12
Filed: 1992-02-12
Abstract: Radioactive compositions containing a calcific matrix and methods for using the compositions for therapeutic radiation treatment including rheumatoid arthritis are disclosed.
Patent EP-0575507-A1 (EP)
Title: Process for recycling amine isomer.
Inventor: BRAISH TAMIM F
IPC: C07B61/00
Filed: 1992-02-07
Abstract: A novel process for converting trans-isomeric N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine to cis-isomeric N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine is disclosed. The process involves contacting trans-isomeric N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine, or a mixture of same with up to about an equal part by weight of the corresponding cis-isomer, with a basic equilibration agent like potassium tert.-butoxide in a reaction-inert polar organic solvent to ultimately afford a cis/trans-mixture wherein the amount of cis-amine present in said mixture achieves a constant value of about 2:1 on a weight-by-weight basis. The aforesaid resultant mixture is useful as an intermediate product that ultimately leads to pure cis-(1S) (4S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenea mine (sertraline), which is a known antidepressant agent.
Patent EP-0596983-A1 (EP)
Inventor: CHAN DOMINIC MING-TAK
IPC: G03C1/06
Filed: 1992-07-24
Abstract: On décrit un nouveau groupe d'hydrazines de fluoroacétylphényle pouvant être utilisées pour assurer le développement accéléré d'éléments de film lithographique. Ces hydrazines permettent non seulement d'obtenir une bonne qualité de points, dans des conditions de développement accéléré, mais peuvent être utilisées à un pH inférieur à celui des éléments classiques de la technique antérieure, et produisent une image moins voilée.
Patent EP-0551481-A1 (EP)
Inventor: SALAMI BAHMAN
IPC: B09B3/00
Filed: 1992-08-04
Abstract: Avant d'éliminer des tubes à rayons cathodiques, notamment des écrans cathodiques, il faut premièrement enlever de leurs éléments ou corps en verre tous enduits éventuels composés essentiellement de carbone, d'acétate de polyvinyle, de métaux et d'autres substances non métalliques, ainsi que des composés phosphorescents. Afin de décaper ces enduits des éléments ou des corps en verre faisant partie des écrans cathodiques, ceux-ci sont immergés dans une solution alcaline contenant des agents tensioactifs dans laquelle les éléments en verre sont exposés à des ultrasons.
Patent EP-0667899-A1 (EP)
Inventor: REDEMANN NORBERT MAX-PLANCK-IN
IPC: A61K38/45
Filed: 1992-09-07
Abstract: Die vorliegende Erfindung betrifft mutierte Rezeptortyrosinkinasen, die sich als Arzneimittel eignen. Besonders vorteilhaft sind die mutierten Wachstumsfaktorrezeptoren zur Behandlung von Krebserkrankungen, insbesondere von solchen Krebsarten, bei denen die Überfunktion von Wachstumsfaktorrezeptoren eine Rolle bei der Krebsentstehung spielt sowie von anderen Krankheiten, die auf der Überfunktion der Rezeptoren beruhen. Als besonders wirksames Arzneimittel zur Behandlung von Krebs werden Mutanten des EGF-Rezeptors offenbart, bei denen die Tyrosinkinaseaktivität des Wildtyp-Rezeptors durch eine Punktmutation oder Deletion in der Tyrosinkinase-Domäne eliminiert worden ist.
Patent EP-0607228-A1 (EP)
Title: Peinture electrostatique au pistolet
Inventor: OUTHWAITE ALAN CHARLES COBBLER
IPC: C09D175/04
Filed: 1992-10-09
Abstract: On décrit des formulations pour peinture électrostatique au pistolet se composant d'alkydes, d'acryliques, de nitrocellulose ou de polyuréthanes présentant des valeurs bien déterminées de viscosité/résistance et à teneur en matières solides filmogènes.